Imaging‐based biological staging associates with brain atrophy in preclinical Alzheimer's disease

Our findings reveal that the imaging-based biological AD staging is closely associated with cortical brain atrophy, showing a gradual acceleration in rates of cortical atrophy across stages. Additionally, our results suggest that serial volumetric measurements of temporoparietal brain regions may be sensitive biomarkers of early disease progression. Taken together, our findings provide valuable insights for applying the imaging-based biological AD staging in preclinical AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_107663
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Imaging‐based biological staging associates with brain atrophy in preclinical Alzheimer's disease

Douglas Teixeira Leffa, Nesrine Rahmouni, Wagner S. Brum, Marco Antônio De Bastiani et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Imaging‐based biological staging associates with brain atrophy in preclinical Alzheimer's disease

Douglas Teixeira Leffa, Nesrine Rahmouni, Wagner S. Brum, Marco Antônio De Bastiani, Firoza Zubeida Lussier, Andrei Bieger, Cristiano Schaffer Aguzzoli, Lydia Trudel, Anderson Silva Corin, Isabela Just de Jesus Vanni, Pamela C.L. Ferreira, João Pedro Ferrari‐Souza, Arthur Macedo, Eduardo R. Zimmer, Joseph Therriault, Lorenzo Fontura Brasil Barcellos, Bruna Bellaver, Marco Antônio Albini Valer, Giovanna Carello‐Collar, Diogo O. Souza, Guilherme Povala, Wyllians Vendramini Borelli, Pedro Rosa‐Neto
article en

Abstract

Our findings reveal that the imaging-based biological AD staging is closely associated with cortical brain atrophy, showing a gradual acceleration in rates of cortical atrophy across stages. Additionally, our results suggest that serial volumetric measurements of temporoparietal brain regions may be sensitive biomarkers of early disease progression. Taken together, our findings provide valuable insights for applying the imaging-based biological AD staging in preclinical AD.

Alzheimer s & DementiaVol. 21(S2)
Universidade Federal do Rio Grande do Sul (BR), Universidade Federal de Pelotas (BR), University of Pittsburgh (US), Hospital São Lucas da PUCRS (BR), Pontifícia Universidade Católica do Rio Grande do Sul (BR), McGill University (CA)
Openalex Percentile: Top 28%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Imaging‐based biological staging associates with brain atrophy in preclinical Alzheimer's disease — Douglas Teixeira Leffa, Nesrine Rahmouni, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS